Lv5
883 积分 2021-12-06 加入
Long-term outcomes of atezolizumab–bevacizumab in unresectable hepatocellular carcinoma: A real-world study
3个月前
已完结
Integrative Application of Traditional Chinese Medicine in Interventional Oncology: A Comprehensive Review
4个月前
已完结
Transarterial chemoembolization combined with immunotherapy plus bevacizumab or lenvatinib for the treatment of unresectable hepatocellular carcinoma: which treatment strategy demonstrates superior efficacy?
4个月前
已关闭
The genomic and immunogenomic landscape of mechanics pathway informs clinical prognosis and response to mechanotherapy
4个月前
已完结
Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab
6个月前
已完结
Combination immunotherapy for hepatocellular carcinoma
6个月前
已关闭
Metastasis-Initiating Cells and Ecosystems
7个月前
已完结
皖公网安备34019202002308
